CORE ADANIPORTS+0.24% BIRET-0.24% BRIGADE-0.85% DLF-1.17% EMBASSY+1.10% GMRAIRPORT+0.00% GODREJPROP+0.19% IRB+3.46% LODHA-0.98% LT-1.76% MAHLIFE-1.64% MINDSPACE-1.39% NCC-0.64% OBEROIRLTY-0.14% PHOENIXLTD+0.11% PRESTIGE-0.22% SOBHA+0.95% as of 2026-08-26 16:27 UTC

The Annexure

Desk› Healthcare› Biofil Chemicals & Pharmaceuticals Ltd

Biofil Chemicals & Pharmaceuticals Ltd

BSE 524396 BIOFILCHEM INE829A01014
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Filing rhythm · 60 trading days

7 filings · 3 material · busiest 2026-08-11

What it files

Newspaper Publication2 Board Outcome1 Results1 Change in Management1 Compliance Certificate1 Trading Window1

Filings

7 in the window

  1. 19 August 2026

    Newspaper Publication

    Newspaper Publication

    Newspaper publication of Notice of 41st AGM through Video Conferencing ('VC')/ Other Audio Visual Means ('OAVM')

    Company Update / Newspaper Publication View filing →

  2. 12 August 2026

    Newspaper Publication

    Newspaper Publication

    Submission of publication of Un-audited Financial Results in the Newspaper pursuant to Regulation 47 of SEBI (Listing Obligation and Disclosure Requirement) Regulations, 2015

    Company Update / Newspaper Publication View filing →

  3. 11 August 2026

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday 11Th August, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

    Outcome of Board Meeting held on Tuesday 11th August, 2026 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

    Board Meeting / Outcome of Board Meeting View filing →

  4. 11 August 2026

    Results

    Un-Audited Financial Results For The Quarter Ended 30Th June 2026

    Un-Audited Financial Results for the quarter ended 30th June 2026

    Result / Financial Results View filing →

  5. 11 August 2026

    Change in Management

    Change in Management

    Continuation of Directorship of Mr. Ashok Kumar Ramawat (DIN: 08818263) as a Non-executive Independent Director of the company, notwithstanding his attaining the age of 75 (Seventy Five )Years

    Company Update / Change in Management View filing →

  6. 1 July 2026

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depository and Participants) Regulations, 2018 for the quarter ended 30th June, 2026.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  7. 25 June 2026

    Trading Window

    Closure of Trading Window

    Closure of Trading Window for the quarter ended 30.06.2026

    Insider Trading / SAST / Closure of Trading Window View filing →